Latest News
Puresta's EVERQ brings AI-led skin assessment and dermatologist care into one platform
The platform is designed to move consumers away from product-led skincare and trial-and-error recommendations towards a more personalised, diagnosis-led approach
Alma Lasers launches Accent Prime in Gurugram
The technology addresses aesthetic concerns related to body shape and skin firmness in selected areas
Neurizon’s ALS therapy to be made available to 200 patients
The NIH-funded programme is expected to provide the NUZ-001 for patients who are otherwise ineligible for clinical trials access for up to 96 weeks
India to roll out digital drug regulatory system soon: DCGI
Dr. Rajeev Singh Raghuvanshi outlined next phase of India’s drug regulatory reforms and also revealed plans to create 1,500 new positions to strengthen CDSCO's internal scientific capabilities
Priyaranjan Jha joins Sandoz as Global Head of GCCs and Country President, India
In his new role, Jha will oversee Sandoz’s GCC operations across Hyderabad, Prague, Mexico City and Madrid
FDA approves Lilly’s Inluriyo-Verzenio combination for advanced breast cancer
Patients receiving Inluriyo plus Verzenio had a median progression-free survival of 11.1 months
Pharma giants join clean heat push as Sanofi, UCB and Opella target supply chain emissions
The program brings together pharmaceutical companies, technical specialists, funding options and clean heat solutions to address barriers that have slowed progress
Teva study identifies what healthcare providers prioritize when treating tardive dyskinesia in older patients
Dose formulation, drug-drug interaction risk and evidence of long-term response followed as additional factors influencing treatment choices
Sartorius and NIBRT to launch global continuous bioprocessing training hub in Dublin
The Process Intensification Training Center in Dublin will provide hands-on training and knowledge-sharing for the biopharmaceutical industry
Real-world VRAYLAR studies show improvements in depression and quality of life
These prospective studies provide additional evidence that VRAYLAR can help patients achieve meaningful improvements in depressive symptoms, functioning and other patient-centered outcomes in routine clinical practice
Roche’s Ocrevus moves closer to EU nod for paediatric MS
The CHMP recommendation is based on results from the Phase III OPERETTA 2 study
Indian Pharma Post is an online platform that provides news and insights on the pharmaceutical industry. It reports on the latest news updates, drug discoveries, and research reports. It highlights trending topics in the entire healthcare universe and will lay emphasis on the new best practices across the spectrum of the industry. It hosts a team of experts who will provide insights on policies that shape developments in the industry.
.jpg)


.jpg)





.jpg)




.jpg)




.jpg)





